| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |